Glaxosmithkline Pharmaceuticals Ltd.

Financial

	Glaxosmithkline Phar	Cipla	Zydus Lifesciences
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	1.6 %	8.9 %	5.2 %
R&D as a % of Total Sales	0.06 %	6.1 %	7.0 %
Financials
5 yr Average ROE	29.77 %	11.43 %	16.63 %
5yr average Equity Multiplier	2.18	1.39	1.82
5yr Average Asset Turnover Ratio	0.84	0.76	0.62
5yr Avg Net Profit Margin	19.97 %	10.96 %	15.64 %
Price to Book	23.04	4.63	5.36
P/E	67.06	31.02	33.74
5yr Avg Cash Conversion Cycle	-71.84 Days	-3.69 Days	-65.67 Days
Inventory Days	55.22 Days	59.85 Days	51.98 Days
Days Receivable	20.34 Days	44.13 Days	41.75 Days
Days Payable	126.45 Days	114.64 Days	168.09 Days
5yr Average Interest Coverage Ratio	453.05	23.71	15.34
5yr Avg ROCE	31.2 %	15.24 %	16.69 %
5yr Avg Operating Profit Margin	24.58 %	22.51 %	23.13 %
5 yr average Debt to Equity	0.0	0.13	0.44
5yr CAGR Net Profit	6.52 %	12.9 %	1.18 %
5yr Average Return on Assets	15.46 %	8.36 %	9.5 %
Shareholdings
Promoter Holding	75.0 %	33.47 %	74.98 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-3.26 %	0.1 %
Change in Mutual Fund Holding (3 Yrs)	0.64 %	2.19 %	0.3 %

Business

	Glaxosmithkline Phar	Cipla	Zydus Lifesciences
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 76.0 Vaccines 24.0 New ventures 0 Emerging Markets 0 Europe Formulatios 0 Alliances 0 API 0 Wellness 0 Animal Health 0 EMB Formulations 0 India Formulations 0 US Formulations 0	Product Wise Break-Up Alliances 0 API 0 Vaccines 0 Wellness 0 Emerging Markets 0 EMB Formulations 0 US Formulations 0 New ventures 4.22 Europe Formulatios 0 India Formulations 0 Animal Health 0 Pharmaceutical 0 Others 95.78	Product Wise Break-Up Alliance 1.0 Active Pharmaceutical Ingredient (API) 3.0 Vaccines 0 Wellness 9.0 Emerging Markets 11.0 EMB Formulations 0 US Formulations 43.0 New ventures 0 Europe Formulatios 0 India Formulations 33.0 Animal Health 0 Pharmaceutical 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 30.55 Anti-Infective 22.25 Vaccines 12.64 Pain Management 11.96 Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Anti-infectives 0 Cardiac 0 Urology 0 Gastro Intestinal 0 Antivirals 0 Derma 0 Pain / Analgesics 0 Neuro /CNS 0 Gynaec. 0 Vitamins 0 Antineoplast 0 Opthal/Otologicals 0 Oncology 0 Anti Diabetic 0 Others 3.27	Therapeutic Area Wise Break-Up - Domestic Vaccines 0 Anti - Diabetes 3.8 Antineoplast 0 Dermatology 0 Anti-Infective 0 Respiratory Systems 38.9 Urology 4.8 Vitamins / Minerals / Nutrients 0 Oncology 0 Pain Management 0 Derma 2.7 Pain Management 3.5 Cardiac Science 11.7 Vitamins 0 Gastro Intestinal 5.8 Gynaec. 0 Central Nervous System (CNS) 2.3 Ophthalmology 3.1 Antivirals 3.1 Hormones 0 Anti-Infective 15.3 Others 5.0	-
Location Wise Break-Up	Location Wise Break-Up India 98.03 Rest of the World 1.97 SAGA 0 Europe 0 Global API 0 Emerging Markets 0 North America 0 USA 0	Location Wise Break-Up North America 29.0 Europe 0 Global API 2.0 SAGA 12.0 Emerging Markets 0 India 44.0 Rest of the World 11.0 USA 0 Others 2.0	Location Wise Break-Up North America 0 Europe 0 Global API 0 SAGA 0 Emerging Markets 0 India 44.32 Rest of the World 0 USA 43.43 Others 12.25
Acute vs Chronic	Acute vs Chronic Acute 99.0 Chronic 1.0	-	-

Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

SIGN UP FOR FREE